Anti-DLL3 Antibody (Rovalpituzumab)
Catalog No.
F1545
Anti-DLL3 Antibody (Rovalpituzumab)
Featured Products
Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-active molecule conjugates (ADCs), Rovalpituzumab Tesirine. Rovalpituzumab has anti-small cell lung cancer (SCLC) activity.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.02 kDa
Dry ice
1613313-01-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Rovalpituzumab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9NYJ7
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human DLL3 His at 2 ug/mL can bind Anti-DLL3 Antibody (Rovalpituzumab)
DLL3
Please avoid freeze-thaw cycles.